Reasearch at TUM's Institute for Medical Microbiology, Immunology and Hygiene: the institute's director, Prof. Dirk Busch, is the speaker of a new Transregional Collaborative Research Center on therapies based on genetically modified immune cells.
Image: Astrid Eckert / TUM
  • Research news
  • Reading time: 3 MIN

Two new DFG Collaborative Research Centers at TUMCRCs to study immunotherapies and photocatalysis

Green light for trailblazing projects: The German Research Foundation (DFG) has approved applications from TUM and partner institutions to fund two new Transregional Collaborative Research Centers (TRRs). TUM scientists will assume the speaker role in TRRs dedicated to photocatalysis and immunotherapies with lymphocytes. The DFG has also approved another new group with TUM involvement and granted extensions to five existing projects.

The DFG Collaborative Research Centers are among the most important research funding programs in Germany. They support complex, interdisciplinary and long-term research initiatives. They are initially approved for four years and can receive funding for up to 12 years. A TRR (or “transregio”) is a CRC with partners cooperating on a trans-regional basis.

TRR 325: Assembly Controlled Chemical Photocatalysis

The basic substances used in many everyday materials are produced with the aid of catalysts. Photocatalysis opens up the way to new approaches and products that would be virtually impossible with conventional processes. The goal of the TRR “Controlling chemical photocatalysis through molecular assemblies” is to develop a new generation of photocatalytic systems for organic synthesis by controlling interactions between catalysts and reactive partners. The long-term objective is to help conserve more energy and resources in light-driven reactions. The speaker is Thorsten Bach, a professor of organic chemistry at TUM. The University of Regensburg is a co-applicant.

Before coming to Munich, Thorsten Bach spent time in Heidelberg, Los Angeles (USC), Marburg, Boston (Harvard) and Münster. He has held the Chair for Organic Chemistry I at TUM since 2000. He is a member of the German Academy of Sciences Leopoldina and the Bavarian Academy of Sciences.

TRR 338: LETSIMMUN

Lymphocytes are a subgroup of the white blood cells. They include the T cells, for example. The TRR "LETSIMMUN - Lymphocyte Engineering for Therapeutic Synthetic Immunity" will investigate – among other questions – how genetically engineered lymphocytes might be used to fight infections, tumors or autoimmune diseases. The group wishes to help establish immunotherapies with modified lymphocytes as a medically safe and effective treatment for as many patients as possible. The speaker is Dirk Busch, Professor of Medical Microbiology, Immunology and Hygiene. Co-applicants are the LMU München and the University of Würzburg.

Dirk Busch has been the director of the Institute for Medical Microbiology, Immunology and Hygiene at TUM since 2009. He is a member of the Leopoldina German Academy of Sciences.

TRR 326: Geometry and Arithmetic of Uniformized Structures (GAUS)

The CRC “Geometry and Arithmetic of Uniformized Structures (GAUS)” will work in the field of theoretical mathematics. The basic idea behind uniformization is to replace complicated geometric objects through simpler ones without changing the local structure. By translating the complexity into another “language”, the group wishes to open up new perspectives on the original objects and make them accessible for central geometric and arithmetic problems. Applicant universities are Frankfurt/Main, Darmstadt and Heidelberg. TUM is represented by Eva Viehmann, Professor of Arithmetic Geometry.

Extended for an additional four years:

SFB 1258 Neutrinos and Dark Matter in Astro- and Particle Physics   

SFB 1320    Everday Activity Sciences and Engineering - EASE    

SFB 1277    Emergent Relativistic Effects in Condensed Matter - From Fundamental Aspects to Electronic Functionality    

SFB 1064    Chromatin Dynamics    

TRR 205    The Adrenal Gland: Central Relay in Health and Disease

Technical University of Munich

Corporate Communications Center

Related articles at www.tum.de

Prof. Thorsten Bach (links) und Prof. Thomas Neumann

Leibniz Prizes for Thorsten Bach and Thomas Neumann

The German Research Foundation (DFG) has awarded two of the 2020 Gottfried Wilhelm Leibniz Prizes to scientists from the Technical University of Munich (TUM): Thorsten Bach, Professor of Organic Chemistry, and Thomas…

Prof. Dirk Busch and Prof. Michael Sattler. (Image: A. Heddergott and A. Eckert / TUM)

Dirk Busch and Michael Sattler become members of Leopoldina

The German National Academy of Sciences Leopoldina has appointed a medical scientist and a chemist from the Technical University of Munich as new members: Prof. Dirk Busch, Professor of Medical Microbiology, Immunology and…

Cell cultures are an important tool for oncologic basic research. (Image: A. Heddergott / TUM)

TUM coordinates two new Collaborative Research Centers

The Technical University of Munich (TUM) has taken on the role of coordinator in two new German Research Foundation Collaborative Research Centers (short SFB for german ‘Sonderforschungsbereich’), both of which are…

Neuronales Netzwerk

Zwei neue Sonderforschungsbereiche mit TUM-Forschern

Die Deutsche Forschungsgemeinschaft (DFG) richtet einen neuen Sonderforschungsbereich (SFB) und einen Transregio (SFB/TRR) ein, an denen Wissenschaftler der TUM beteiligt sind. Der SFB erforscht, wie akuter Schmerz…